DrugPatentWatch

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Patent: 6,319,913

Summary for Patent: 6,319,913

Title: Penetration enhancing and irritation reducing systems
Abstract:This invention lies in the technology of transdermal and topical drug delivery. In particular, the present invention relates to enhancement of the penetration of transdermally or topically applied drugs and with the reduction of skin irritation that often accompanies transdermal and topical drug delivery.
Inventor(s): Mak; Vivien H. W. (Menlo Park, CA), Grayson; Stephen (San Rafael, CA)
Assignee: Cellegy Pharmaceuticals, Inc. (South San Francisco, CA)
Application Number:09/189,090
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Patented / Exclusive Use
Endo Pharms
FORTESTA
testosterone
GEL, METERED; TRANSDERMAL021463Dec 29, 2010RXYes6,319,913<disabled>TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Patent activity for: 6,319,913

Failure to pay maintenance fee
Patent Number:6,319,913 Application Number:09/189,090 Issue Date:Nov 20 2001 Expiration Date:Nov 20 2009
Failure to pay maintenance fee
Patent Number:6,319,913 Application Number:09/189,090 Issue Date:Nov 20 2001 Expiration Date:Nov 20 2009
Reinstatement due to payment of a late maintenance fee
Patent Number:6,319,913 Application Number:09/189,090 Issue Date:Nov 20 2001 Filing Date:Nov 09 1998 Granted Date:Dec 01 2010

International Patent Family for Patent: 6,319,913

Country Document Number Publication Date
WIPO (PCT)9924041May 20, 1999
United States2002058650May 16, 2002
United States2003166625Sep 04, 2003
United States6579865Jun 17, 2003
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.


« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639

`abc